T38N (p.Thr38Asn) variant of AGL (Glycogen debranching enzyme)

T38N (p.Thr38Asn) in AGL (Glycogen debranching enzyme) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Glycogen storage disease type III. The available variant effect predictions contribute to a CATVariant prioritization score of 0.20 / 1. The record also includes structural context.

T38N (p.Thr38Asn) variant details